Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Orbimed Capital LLC

Orbimed Capital LLC

Private equity with venture activity · probableNew York, NYorbimed.comSEC registered investment adviserpart of OrbiMed

One of 2 advisers that share orbimed.com; the firm is OrbiMed. Orbimed Advisors LLC. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

registered adviser; venture funds are 0% of 1 private funds

Importance
35
elevated
Active deployment
11
low
Emerging
0
low
Completeness
63
high
Freshness
97
high
Research priority
10
low
Identity and regulatory footprint
Headquarters
New York, NYadviserinfo.sec.gov
Office address
601 LEXINGTON AVENUE, 54TH FLOOR, New York, NY, 10022adviserinfo.sec.gov
Business phone
212-739-6400adviserinfo.sec.gov
Website
HTTP://WWW.ORBIMED.COM
SEC adviser type
registered investment adviseradviserinfo.sec.gov
SEC exemption claimed
unknown
Latest Form ADV
Mar 29, 2016
Private funds reported
1 (0 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$3.4Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Regulatory AUM
$8.0Bthe adviser's RAUM, a regulatory measure, never a fund size
Employees
91
business phone
212-739-6400adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
3 observed deals
Stated (the firm’s website)
Sectors
ai, healthcare, biotech, medtech, media
Stages
growth, early
Geography
global, globally, worldwide
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 3
Funds and vehicles
0 reported, 1 no longer reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Orbimed Associates LLCSPV or co-invest vehicle · ADV: Other Private FundunknownWound down$109,000
Jul 11, 2014
35unknownunknown
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
9 current, 1 departed
Samuel David Isaly
Managing Member · since Feb 1, 2000
Managing partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Carl Lee Gordon
Member · since Jan 1, 1998
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Geoffrey Che-Chang Hsu
Member · since Jan 1, 2010
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Jonathan Todd Silverstein
Member · since Jan 1, 2005
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Sven Heinz Borho
Member · since Oct 1, 1998
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
William Carter Neild
Member · since Jan 1, 2007
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Alexander Matthew Cooper
General Counsel · since Jul 1, 2010
Platform and operations
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Douglas W. Coon
Chief Compliance Officer · since Feb 1, 2016
Platform and operations
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Evan Dean Sotiriou
Chief Financial Officer · since Oct 1, 2011
Platform and operations
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
1 departed (kept with end dates)
Investments on record
3 edges, 3 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
Cookiedatabaseportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Telios Pharma Incportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
worldportfolio listingunknownunknownunknownunknownSep 12, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
31 relationships from shared deals, counted for the whole firm
SHD Partners 1 shared · one timeVariant 1 shared · one timeInflection Managing Partner Inc. 1 shared · one timeCNK Equity Partners I, LLC 1 shared · one timeAlpha Partners Management, LLC 1 shared · one timeRockwood Equity Partners LLC 1 shared · one timeYork Investments Holdings, LLC 1 shared · one timeCota Capital Management, LLC 1 shared · one timeOmega Venture Partners 1 shared · one timeArboretum Ventures 1 shared · one timeRice Park Capital 1 shared · one timeNTI Managers, LLC 1 shared · one timePlexo Capital Management, LLC 1 shared · one timeSUN Mountain Capital Advisors, LLC 1 shared · one timeOriza Holdings 1 shared · one time · we led 1TCGX 1 shared · one time · we led 1Cenova Capital 1 shared · one time · we led 1TCG Crossover 1 shared · one time · we led 1LAV 1 shared · one time · we led 1Decheng Capital LLC 1 shared · one time · they led 1Loyal Valley Capital 1 shared · one time · they led 1Qiming 1 shared · one timeHSG 1 shared · one timeGaorong Ventures 1 shared · one timeArch Venture Partners 1 shared · one time · they led 1 · we led 1Axon Ventures 1 shared · one time · we led 1Balyasny Asset Management L.P. 1 shared · one time · we led 1Cormorant Asset Management 1 shared · one time · we led 1Section 32, LLC 1 shared · one time · we led 1Prebys Ventures 1 shared · one time · we led 1LYFE Capital 1 shared · one time · we led 1
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
5 dated events
  1. Mar 29, 2016
    Orbimed Associates LLC no longer reported on Form ADV by Orbimed Capital LLC
    Fund no longer reportedFundsInferenceOrbimed Associates LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Feb 1, 2016
    Douglas W. Coon joined Schedule A of Orbimed Capital LLC as Chief Compliance Officer
    Person joinedPeopleFactDouglas W. CoonSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Mar 31, 2014
    Michael Bart Sheffery (Member) no longer on Schedule A of Orbimed Capital LLC
    Person leftPeopleInferenceMichael Bart ShefferySEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  4. Mar 7, 2012
    Orbimed Capital LLC first filed Form ADV (IA)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  5. Mar 7, 2012
    Orbimed Associates LLC first reported on Form ADV by Orbimed Capital LLC (Venture Capital Fund), GAV $343,000
    Fund first reported on Form ADVFundsFactOrbimed Associates LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Private equity with venture activity (probable, 75%, cls-1)
    registered adviser; venture funds are 0% of 1 private funds
Evidence
32 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC adviser typeregistered_investment_adviserMar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-03-07Mar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2016-03-29Mar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds0Mar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone212-739-6400Mar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Employees91Mar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersNew York, NYMar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address601 LEXINGTON AVENUE, 54TH FLOOR, New York, NY, 10022Mar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://www.orbimed.com/portfolio/
“3 entries read”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported1Mar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$3.4BMar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Regulatory AUM (adviser, not fund size)$8.0BMar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyglobal,globally,worldwide
“geography words on the home page”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsai,healthcare,biotech,medtech,media
“sector words on the home page”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesgrowth,early
“stage words on the home page”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://www.orbimed.com/leadership/
“0 name/title pairs read”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported0Mar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://WWW.ORBIMED.COMMar 29, 2016FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleHomepage - OrbiMed
“title tag”
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)